NTBLQ (Notable Labs) ROE % Adjusted to Book Value: -265.36% (As of Jun. 2024)


What is Notable Labs ROE % Adjusted to Book Value?

Notable Labs NTBLQ -90.00% ROE % Adjusted to Book Value is -265.36% as of Jun. 2024.

Notable Labs's ROE % for the quarter that ended in Jun. 2024 was -222.90%. Notable Labs's PB Ratio for the quarter that ended in Jun. 2024 was 0.84. Notable Labs's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -265.36%.

Notable Labs ROE % Adjusted to Book Value Related Terms

Notable Labs ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Notable Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs ROE % Adjusted to Book Value Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
0.00 0.00 0.00

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 0.00 -81.89 -265.36

NTBLQ vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Notable Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Notable Labs's ROE % Adjusted to Book Value falls into.


Notable Labs ROE % Adjusted to Book Value Calculation

Notable Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 1.13
=0.00%

Notable Labs's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-222.90% / 0.84
=-265.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -265.36% mean?
Notable Labs (NTBLQ) has a ROE % Adjusted to Book Value of -265.36% as of Jun. 2024. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Notable Labs and its competitors.
Is Notable Labs' ROE % Adjusted to Book Value too high?
Notable Labs' current ROE % Adjusted to Book Value is -265.36%.
How does Notable Labs' ROE % Adjusted to Book Value compare to VRTX and REGN?
Notable Labs' ROE % Adjusted to Book Value of -265.36% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Notable Labs and its competitors. Notable Labs's current ROE % Adjusted to Book Value is -265.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current ROE % Adjusted to Book Value of -265.36%. The current ROE % Adjusted to Book Value is -265.36%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current ROE % Adjusted to Book Value is -265.36% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.